---
figid: PMC9669483__fphar-13-1031804-g008
pmcid: PMC9669483
image_filename: fphar-13-1031804-g008.jpg
figure_link: /pmc/articles/PMC9669483/figure/F8/
number: FIGURE 8
figure_title: ''
caption: The proposed role of MEF2C in the inflammatory pathogenesis of MTrPs.
article_title: Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial
  trigger points via TNF-α/ NF-κB signaling pathway in rats.
citation: Mingjian Liu, et al. Front Pharmacol. 2022;13:1031804.
year: '2022'

doi: 10.3389/fphar.2022.1031804
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- inflammation
- inflammatory hypertrophy
- myocyte enhancer factor 2C
- chronic pain
- myofascial pain syndrome

---
